⚠ DIAGNOSTIC PHASE — TREATMENT PLAN NOT YET APPLICABLEDIAGNOSTIC PHASE — TREATMENT PLAN NOT YET APPLICABLE. Histology required before any therapy discussion (CHARTER §15.2 C7).
Patient
PZ-DIAG-HCC-001 · suspicion lineage: hepatocellular_carcinoma
Tissues: liver · Hypotheses: DIS-HCC
59M HCV-cirrhosis (Child-Pugh A6, MELD 9) post-DAA sofosbuvir/velpatasvir 12 weeks → SVR12 confirmed 4 years ago. On surveillance US-q6mo + AFP. New 3.8 cm hepatic mass detected on routine US (right hepatic lobe segment 7), AFP rose 12 → 480 ng/mL over 6 months. Multi-phase contrast CT: arterial_phase_hyperenhancement + portal_venous_washout + capsular appearance → LI-RADS_5 (definitive HCC by imaging in cirrhotic patient per AASLD criteria). No portal vein invasion, no extrahepatic disease. Esophageal varices grade 1 on prior EGD (2 years ago — needs re-screening pre-systemic Tx). Eligible for systemic therapy or curative bridging (TACE/transplant) per BCLC.
Matched workup: WORKUP-SUSPECTED-HCC · Очікуваний термін: ~ дnoв
Workup steps (8)
- 1lab Alpha-fetoprotein (serum)
Diagnostic + prognostic + monitoring biomarker for HCC.
- 2imaging CT chest + abdomen + pelvis with IV contrast
CRC staging — detects nodal and distant (liver, lung, peritoneal) metastases.
- 3lab Liver Function Tests
Assess hepatic function — baseline + during BR cycles + DAA therapy + HBV reactivation monitoring.
- 4consult Child-Pugh classification calculation
Composite of bilirubin + albumin + INR + ascites + encephalopathy → A (5-6) / B (7-9) / C (10-15). Determines HCC therapy eligibility.
- 5lab Complete Blood Count with Differential
Baseline cytopenia assessment and ongoing monitoring of myelosuppression.
- 6imaging Esophagogastroduodenoscopy with varices assessment
Mandatory pre-atezo+bev screening for varices in HCC + cirrhosis. High-risk varices need ligation/banding before initiation.
- 7lab Hepatitis B Serology Panel
Mandatory before any anti-CD20 therapy or rituximab-containing regimen — identify HBV reactivation risk.
- 8lab HCV Antibody (Anti-HCV)
Скриnoнг на HCV. Якщо позитивний → confirm з HCV RNA quantitative (TEST-HCV-RNA). Mandatory для лімфомного workup (HCV-associated MZL, B-cell lymphomas) і перед anti-CD20.
MDT brief
MDT talk tree (3 steps)
| # | Owner | Topic | Action |
|---|
| 1 | pathologist | Specialist review | Any suspicion requires biopsy — pathologist plans site selection, IHC panel, ancillary tests. |
| 2 | radiologist | Specialist review | Stage / restaging imaging + biopsy guidance — radiologist. |
| 3 | surgical_oncologist | Specialist review | Suspected solid tumor — resectability assessment, biopsy approach. |
Skills (required) — mandatory virtual specialists (2)
- Pathologist (general) required
Any suspicion requires biopsy — pathologist plans site selection, IHC panel, ancillary tests.
- Radiologist required
Stage / restaging imaging + biopsy guidance — radiologist.
Skills (recommended) — for consideration (1)
Technical MDT skill metadata (3/16 activated in this plan)
All registered virtual specialists. ✓ — activated for this case; ○ — not activated (available for other clinical scenarios).
| Specialist | skill_id | Version | Last reviewed | Sign-offs | Domain |
|---|
| Cellular therapy specialist (CAR-T) | cellular_therapy_specialist | v0.1.0 | 2026-04-25 | 0 | cellular_therapy |
| Clinical pharmacist | clinical_pharmacist | v0.1.0 | 2026-04-25 | 0 | clinical_pharmacy |
| Hematologist / oncohematologist | hematologist | v0.1.0 | 2026-04-25 | 0 | hematology_oncology |
| Hematopathologist (lymphoma / leukemia / myeloma) | hematopathologist | v0.1.0 | 2026-04-25 | 0 | hematopathology |
| Infectious disease / hepatology | infectious_disease_hepatology | v0.1.0 | 2026-04-25 | 0 | infectious_diseases |
| Medical oncologist (solid-tumor chemotherapist) | medical_oncologist | v0.1.0 | 2026-04-25 | 0 | solid_oncology |
| Molecular geneticist / molecular oncologist | molecular_geneticist | v0.1.0 | 2026-04-25 | 0 | molecular_oncology |
| Palliative care | palliative_care | v0.1.0 | 2026-04-25 | 0 | palliative_care |
| Pathologist (general) | pathologist | v0.1.0 | 2026-04-25 | 0 | pathology |
| Primary care / family physician | primary_care | v0.1.0 | 2026-04-25 | 0 | primary_care |
| Psycho-oncologist | psychologist | v0.1.0 | 2026-04-25 | 0 | psychosocial |
| Radiation oncologist | radiation_oncologist | v0.1.0 | 2026-04-25 | 0 | radiation_oncology |
| Radiologist | radiologist | v0.1.0 | 2026-04-25 | 0 | diagnostic_imaging |
| Social worker / case manager | social_worker_case_manager | v0.1.0 | 2026-04-25 | 0 | psychosocial |
| Surgical oncologist | surgical_oncologist | v0.1.0 | 2026-04-25 | 0 | surgical_oncology |
| Transplant specialist (BMT) | transplant_specialist | v0.1.0 | 2026-04-25 | 0 | cellular_therapy |